Completed Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer NCT00405405 Conditions Endocrine Gland Neoplasms, Endocrine System Diseases, Head and Neck Cancer, +25 more Locations Thomas Jefferson University — Philadelphia, Pennsylvania, United States View Trial Details
Active, Not Recruiting Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) NCT02628067 Conditions Adenocarcinoma, Adenoma, Advanced Cancer, +88 more Locations Not specified View Trial Details
